Abstract. Transgenic rats have been used as model animals for human diseases and organ transplantation and as animal bioreactors for protein production. In general, transgenic rats are produced by pronuclear microinjection of exogenous DNA. Improvement of post-injection survival has been achieved by micro-vibration of the injection pipette. The promoter region, structural gene, chain length and strand ends of the exogenous DNA are not involved in the production efficiency of transgenic rats. Exogenous DNA prepared at 5 μg/ml seemed to be better integrated than lower and higher concentrations. Intracytoplasmic sperm injection (ICSI) has been successfully achieved in rats using a piezo-driven injection pipette. The ICSI technique has not only been applied to rescue infertile male strains but also to produce transgenic rats. The optimal DNA concentration for the ICSI-tg method (0.1 to 0.5 μg/ml) is lower than that for the conventional pronuclear microinjection. Production efficiency was improved when the membrane structure of the sperm head was partially disrupted by detergent or ultrasonic treatment before exposure to the exogenous DNA solution. For successful production of transgenic rats with a modified endogenous gene, establishment of embryonic stem cell lines or alternatively male germline stem cell lines and technical development of somatic cell nuclear transfer are still necessary for this species. Key words: DNA microinjection, Intracytoplasmic sperm injection (ICSI)-mediated transgenesis, Transgenic rat (J. Reprod. Dev. 54: [95][96][97][98][99] 2008) ransgenic rats have been used as model animals for human diseases (e.g., Alzheimer's disease, autoimmunity and highdensity lipoprotein metabolism) [1] [2] [3] and organ transplantation [4] and as animal bioreactors for protein production [5, 6] . The advantage of using rats in transgenic studies would be the ease of continuous or repeated collection of secreted samples (e.g., blood or urine) and various surgical treatments due to the larger size of rats compared with mice, while the litter size, gestation period, maturation rate, estrus cycle length and lifespan of rats are almost comparable with those of mice. Thus, the rat has the advantage of being a somewhat-characterized and intermediate-sized rodent without the economic disadvantage of larger animals and without the technical disadvantage of smaller rodents. Successful production of transgenic rats was first reported at three independent laboratories [2, 7, 8] by pronuclear microinjection of exogenous DNA, the most convenient and reproducible technique of producing transgenic animals. In addition, exogenous DNA has been introduced into the mouse and pig genomes using spermatozoa as the vector under a conventional IVF technique [9, 10] . While the reproducibility of the sperm-mediated DNA transfer technology is still questionable [11, 12] , it has been reported that transgenic mice can be produced when sperm heads and an exogenous DNA solution are mixed and co-injected into oocytes using the ICSI technique [13] . In that study, the efficiency of producing transgenic mice by ICSI-mediated DNA-transfer (3.8 to 4.5% per transferred embryo) was in the range obtained by pronuclear DNA microinjection. Here in, rat transgenesis by pronuclear DNA microinjection (PNMI-tg method) and ICSI-mediated transgenesis (ICSI-tg method) are reviewed.
(J. Reprod. Dev. 54: [95] [96] [97] [98] [99] 2008) ransgenic rats have been used as model animals for human diseases (e.g., Alzheimer's disease, autoimmunity and highdensity lipoprotein metabolism) [1] [2] [3] and organ transplantation [4] and as animal bioreactors for protein production [5, 6] . The advantage of using rats in transgenic studies would be the ease of continuous or repeated collection of secreted samples (e.g., blood or urine) and various surgical treatments due to the larger size of rats compared with mice, while the litter size, gestation period, maturation rate, estrus cycle length and lifespan of rats are almost comparable with those of mice. Thus, the rat has the advantage of being a somewhat-characterized and intermediate-sized rodent without the economic disadvantage of larger animals and without the technical disadvantage of smaller rodents. Successful production of transgenic rats was first reported at three independent laboratories [2, 7, 8] by pronuclear microinjection of exogenous DNA, the most convenient and reproducible technique of producing transgenic animals. In addition, exogenous DNA has been introduced into the mouse and pig genomes using spermatozoa as the vector under a conventional IVF technique [9, 10] . While the reproducibility of the sperm-mediated DNA transfer technology is still questionable [11, 12] , it has been reported that transgenic mice can be produced when sperm heads and an exogenous DNA solution are mixed and co-injected into oocytes using the ICSI technique [13] . In that study, the efficiency of producing transgenic mice by ICSI-mediated DNA-transfer (3.8 to 4.5% per transferred embryo) was in the range obtained by pronuclear DNA microinjection. Here in, rat transgenesis by pronuclear DNA microinjection (PNMI-tg method) and ICSI-mediated transgenesis (ICSI-tg method) are reviewed.
Production of Transgenic Rats by the PNMI-tg Method

A technical improvement on how to microinject the DNA
In a previous report [7] , DNA microinjection was successfully performed in only 624 of 1,589 (39%) pronuclear rat zygotes, while a total of 117 (20%) offspring resulted from transfer of 591 surviving zygotes. Among these offspring, 13 were found to be transgenic (the overall efficiency of producing transgenic rats was as low as 0.8%). The pronuclear-stage rat zygotes seem to be sensitive to mechanical piercing of the plasma membrane and seem to have a sticky pronuclear membrane. Even though attention has been given to use of an injection pipette with a minimal outer diameter and a sharp tip and to introduce the pipette into the pronucleus as quickly as possible, considerable loss of zygotes occurs due to DNA microinjection [2, 5, 6] . Improvement of post-injection survival has been achieved by micro-vibration of the injection pipette, which is induced by softly touching the stage of the microscope with a finger to pierce the pronuclear membrane (Dr. Paul Verma, Monash University, personal communication). Comparison of post-injection survival using a single DNA construct (bαS1CN/ hGH) and matured Wistar rat-derived pronuclear zygotes showed survival rates of 97% (224/231) [14] and 38% (288/757) [6] for DNA-injected zygotes by the micro-vibration and classical methods, respectively. Strong and quick introduction of the injection pipette into the rat pronucleus is no longer necessary. The overall Accepted for publication: December 14, 2007 Correspondence: M. Hirabayashi (e-mail: mhirarin@nips.ac.jp) efficiency of producing transgenic rats is improved from 1.1% (8/ 757) [6] to 3.5% (8/231) [14] .
Factors affecting production efficiency of transgenic rats
In a series of transgenic rat production, 359 founders of transgenic rats were produced by pronuclear microinjection using 42 kinds of exogenous DNA; this allowed for retrospective factor analysis of the DNA (Table 1 ) [15] . The promoter region (tissuespecific vs. non tissue-specific), structural gene (genomic vs. cDNA), chain length (<2.0, 2.1-4.0, 4.1-6.0 and >6.1 kb) and strand ends of the exogenous DNA (similar vs. dissimilar) were not involved in the production efficiency of transgenic rats. Brinster et al. [16] reported that the production efficiency of transgenic mice was not influenced by the chain length and strand ends of the exogenous DNA. Different concentrations of exogenous DNA (ranging from 0.5 to 50 μg/ml) did not influence the survivability of the zygotes after pronuclear microinjection but did influence development to full-term offspring in a dose-dependent manner (Fig. 1) . A similar trend was observed in the process of transgenic mouse production, and their recommended concentration of exogenous DNA was 1 μg/ml [16] . The highest production efficiency for transgenic rats was obtained when 5 μg/ml of the exogenous DNA was microinjected.
There are preferable strains for production of transgenic rats (Table 2) . Post-injection survival of DNA injected zygotes is not significantly different among the Wistar, LEW and DA strains. However, the overall efficiency of producing transgenic LEW rats is significantly influenced by a lower offspring rate. The efficiency of producing transgenic rodents by pronuclear DNA microinjection using inbred strains (e.g., C57BL/6 and DBA/2 mice and LEW and F344 rats) is generally low compared with those using outbred (e.g., Wistar and SD rats) or hybrid strains (e.g., B6D2F1 and B6C3F1 mice), and is probably due to the low offspring rate of the transferred zygotes.
Production of Transgenic Rats by the ICSI-tg Method
Successful application to rat transgenesis
Perry et al. [13] were the first researchers to report effective production of transgenic mice by the ICSI-tg method. Our previous finding that viable rat offspring can be produced by a piezo-ICSI procedure [17] made it possible to examine and confirm the reproducibility of the ICSI-tg method in rats [18] . There may be a possible advantage to applying ICSI for rat transgenesis in strains with unique genetic characteristics from which recovery of pronuclear-stage fertilized zygotes is difficult . Since the time and space required for animal care can also be significantly reduced, the ICSI-tg method could become a possible alternative to the conventional PNMI-tg method under such circumstances. The standard protocol for the ICSI-tg method includes (1) isolation of sperm heads and partial disruption of acrosomal/plasma membranes, (2) co-incubation of the sperm heads with exogenous DNA solution, (3) piezo-ICSI followed by temporal in vitro culture and embryo transfer to foster mothers and (4) identification of transgenes in the newborn offspring. Linearized exogenous DNA (dsDNA in common) is exposed to the isolated sperm heads at an ambient temperature for only 1 min. There is a considerable difference in the optimal DNA concentration for sperm treatment between mice and rats (in a model case that EGFP DNA is used). The concentration of exogenous DNA solution used for exposure to mouse sperm heads is 5 μg/ml [19] or 5 to 10 μg/ml [13] . However, the optimal concentration of EGFP DNA solution for exposing to rat sperm heads is 0.1 μg/ml [20] or 0.5 μg/ml [18] , and ICSI after exposure to 5 μg/ml DNA has resulted in no development beyond the fourcell stage in vitro (Fig. 2) . Due to the larger surface area of the sperm heads of rats compared with mice, exposure to a higher concentration of exogenous DNA may lead to excess DNA association to the sperm heads and introduction into oocytes by ICSI, which may have a toxic effect on development of oocytes derived from the ICSI-tg method.
The production efficiency of transgenic rats by the PNMI-tg and ICSI-tg methods have been directly compared using six DNA constructs [21] . No significant difference was found in the production efficiency of PCR-positive transgenic rats between the ICSI-tg and PNMI-tg methods by a non-parametric paired t-test (p=0.22; DNA code-A 1.1 vs. 0.9%, code-B 1.3 vs. 0.2%, code-C 3.1 vs. 2.4%, code-D 1.7 vs. 0.5%, code-E 0.2 vs. 2.2%, code-F 0.2 vs. 0%, respectively). Nevertheless, the advantage of the ICSI-tg method for production of transgenic rats would be emphasized in cases in which a low yield of pronuclear zygotes is inevitable for a particular rat strain (inbred or mutant strain) or in cases in which preparation of a sufficient amount of exogenous DNA is difficult.
Factors affecting production efficiency of transgenic rats
Disruption of the spermatozoal membrane would facilitate binding of exogenous DNA molecules to sperm heads. Different procedures have been used to induce disruption; treatment with detergent (e.g., Triton X-100) [13] , freeze-thawing [13, 22] and freeze-drying [13, 22] have been reported for mouse spermatozoa, while ultrasonic treatment combined with or without freeze-thawing [18, 20] has been applied for rat spermatozoa (Fig. 2) . The ultrasonic treatment has been considered to have an adverse effect on mouse spermatozoa or ICSI oocytes [23] ; however, ultrasonic treatment per se does not seem to be detrimental to the sperm chromosomes in the mouse [24] . We have previously reported that the EGFP-transgenic rats produced by the ICSI-tg method transmitted the transgenes to their G1 progeny according to the Mendelian fashion [20] , suggesting that the transgenes were stably integrated into rat chromosomes, as already reported for mice [13, 22] . A wide range of exogenous DNA sizes (chain length of 3.0 to 208 kbp) was applicable to production of transgenic rats by the ICSI-tg method [20] , as also reported for the production of transgenic mice (range of 11.9 to 170 kbp) [22] . Long cassette DNA at >100 kbp, such as BAC, YAC and MAC, is often used to avoid a positional effect on expression of exogenous DNA. Since the ICSI-tg method includes the use of an injection pipette larger than that used in the pronuclear DNA microinjection procedure, the longer DNA may be favorably introduced without mechanical damage by the ICSImediated procedure. More attention should be paid to the composition of the buffers in which sperm heads are prepared and exposed to the exogenous DNA solution, because chelating divalent cations by EDTA/EGTA is effective for stabilizing the paternal chromosomes during early embryogenesis [19] . In regard to rat strain in relation to the efficiency of producing transgenic rats by the ICSItg method, the offspring rates per transferred zygote of the F344 (23%) and LEW strains (29%) were lower than that of the SD strain (47%), and the efficiency of producing transgenic rats of the LEW strain (0.9% of the transferred embryos) was lower than that of the SD strain (8.2% of the transferred embryos) [20] . In addition, gametes from inbred strains may be sensitive to exposure to the exogenous DNA and/or in vitro circumstances. F1 hybrid female mice are often used as oocyte donors for the ICSI-tg method [13, ab a, b Different superscripts within columns denote significant differences (P<0.05).
Fig. 2.
Overall production efficiency of EGFP-expressing transgenic rat embryos as a function of the concentrations of DNA exposed to sonicated and/or cryopreserved sperm heads. a-c Different letters above the columns for each sperm treatment denote significant differences among the DNA concentrations (P<0.05). * Asterisks denote significant differences among the sperm treatments. 19, 22, 25] . Although use of F1 hybrid rats (Donryu × LEW) results in a moderate production efficiency of transgenic rats (3.3% of the transferred embryos) [20] , combination of two rat strains for the hybrid design may be among the factors affecting the efficiency.
Future Perspective for Knock-out (KO) Rat Production
Because the rat is used especially in the research field of neuroscience, development of a methodology to produce "KO rats" has long been desired. The most convenient method for production of KO animals is to use gene-targeted embryonic stem (ES) cells in germline chimera production; however, rat ES cell lines have not yet been established regardless of the world-wide numerous efforts. Alternatively, KO animals can be produced by applying a cloning technology with nuclear transplantation (NT), as reported in sheep [26] and pigs [27] . Successful production of cloned rats with somatic cells was first reported by Zhou et al. (2003) [28] , but the reproducibility of the data is still questionable. As to reasons why the rat cloning by NT is difficult, rat oocytes are likely to activate spontaneously in vitro after recovery from the oviductal ampullae [29] , and are more sensitive to Sr 2+ treatment than mouse oocytes [30] . In addition, the potential of rat oocytes to support the premature chromosome condensation of injected nuclei and subsequent pronucleus-like vesicle formation of injected nuclei is dependent on the characteristics of the oocytes, such as age or strain of donor rats, as well as the timing of oocyte recovery [31] .
The male germline stem (GS) cell line, which is capable of culturing and differentiating in vitro, is an alternative source of cells for production of KO animals (via microinsemination), but studies related to this have been limited to the mouse [32] [33] [34] . Considering the latter strategy, interspecies spermatogonial transplantation offers a unique opportunity for studying spermatogenesis as well as for assaying spermatogonial stem cells. When rat spermatogonial stem cells were transplanted into busulfan-treated nude mouse testes, microinsemination of the retrieved rat spermatids and spermatozoa into rat oocytes resulted in viable rat offspring (Fig. 3 ) [35] . In summary, ES/GS cell technology or animal cloning technology combined with homologous recombination-based gene targeting technology will become a powerful tool for production of KO rats once it is established. Fig. 3 . Birth of EGFP-expressing pups derived from ooplasmic injection of round spermatids to which rat spermatogonial stem cells differentiated in testes of nude mice.
